Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
NEPH Stock Forecast 2026-2027
$3.78
Current Price
$40.82M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to NEPH Price Targets
+111.6%
To High Target of $8.00
+85.2%
To Median Target of $7.00
+58.7%
To Low Target of $6.00
NEPH Price Momentum
+4.1%
1 Week Change
+20.0%
1 Month Change
+3.6%
1 Year Change
-22.5%
Year-to-Date Change
-41.1%
From 52W High of $6.42
+42.1%
From 52W Low of $2.66
๐ TOP ANALYST CALLS
Did NEPH Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Nephros is one of their latest high-conviction picks.
Latest NEPH Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, NEPH has a bullish consensus with a median price target of $7.00 (ranging from $6.00 to $8.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $3.78, the median forecast implies a 85.2% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Anthony Vendetti at Maxim Group, suggesting a 58.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NEPH Analyst Ratings
2
Buy
0
Hold
0
Sell
NEPH Price Target Range
Low
$6.00
Average
$7.00
High
$8.00
Current: $3.78
Latest NEPH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NEPH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 8, 2025 | Maxim Group | Anthony Vendetti | Buy | Maintains | $6.00 |
| Nov 12, 2024 | Benchmark | Speculative Buy | Reiterates | $N/A | |
| May 15, 2024 | Benchmark | Speculative Buy | Reiterates | $N/A | |
| Mar 8, 2024 | Benchmark | Speculative Buy | Upgrade | $N/A | |
| Jan 26, 2021 | B. Riley FBR | Buy | Initiates | $12.50 | |
| Jan 26, 2021 | B. Riley Securities | Buy | Initiates | $N/A | |
| Nov 25, 2020 | Benchmark | Speculative Buy | Initiates | $N/A | |
| Nov 25, 2020 | Maxim Group | Buy | Initiates | $N/A | |
| Oct 24, 2019 | Benchmark | Speculative Buy | Initiates | $N/A | |
| Oct 4, 2019 | Maxim Group | Buy | Initiates | $N/A |
Nephros Inc. (NEPH) Competitors
The following stocks are similar to Nephros based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nephros Inc. (NEPH) Financial Data
Nephros Inc. has a market capitalization of $40.82M with a P/E ratio of 53.7x. The company generates $19.12M in trailing twelve-month revenue with a 4.1% profit margin.
Revenue growth is +6.9% quarter-over-quarter, while maintaining an operating margin of +1.9% and return on equity of +7.8%.
Valuation Metrics
Market Cap
$40.82M
Enterprise Value
$36.47M
P/E Ratio
53.7x
PEG Ratio
-0.7x
Price/Sales
2.1x
Growth & Margins
Revenue Growth (YoY)
+6.9%
Gross Margin
+57.4%
Operating Margin
+1.9%
Net Margin
+4.1%
EPS Growth
-74.9%
Financial Health
Cash/Price Ratio
+9.8%
Current Ratio
4.5x
Debt/Equity
9.0x
ROE
+7.8%
ROA
+3.3%
๐ก SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Nephros Inc. (NEPH) Business Model
About Nephros Inc.
What They Do
Develops and sells filtration and ultrafiltration devices.
Business Model
Nephros Inc. generates revenue through the development and sale of specialized filtration devices, including hemodiafilters and ultrafilters, primarily to medical institutions, commercial facilities, and the military sector. The company focuses on creating high-quality solutions that address the critical needs of clean water and effective dialysis treatments, thereby establishing a robust client base in various healthcare and industrial applications.
Additional Information
Nephros's innovative technology enhances safety and operational efficiency, significantly impacting sectors such as healthcare equipment manufacturing, water treatment, and hospitality services. By improving public health standards and patient outcomes, the company positions itself as a critical player in addressing global health challenges.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
36
CEO
Mr. Robert Banks
Country
United States
IPO Year
2004
Website
www.nephros.comNephros Inc. (NEPH) Latest News & Analysis
Latest News
Quick Summary
Nephros, Inc. announced news via PRISM MediaWire on July 6, 2026. Further details about the announcement were not provided in the excerpt.
Why It Matters
The mention of Nephros, Inc. could indicate new developments or announcements that may impact its stock performance or market position, prompting investor interest and potential action.
Source: MCAP MediaWire
Market Sentiment:
Neutral
Quick Summary
Nephros, Inc. (Nasdaq: NEPH) has been added to the Russell Microcapยฎ Index following the 2026 annual reconstitution, enhancing its visibility in the market.
Why It Matters
Inclusion in the Russell Microcap Index can enhance visibility and liquidity for Nephros, potentially attracting institutional investment and positively impacting share price.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Nephros to Host Virtual Investor Event: โBeyond Filtration: The Nephros Model in Actionโ
1 month ago
Quick Summary
Nephros, Inc. (Nasdaq: NEPH) will host a virtual investor event on July 16, 2026, titled โBeyond Filtration: The Nephros Model in Action.โ
Why It Matters
Nephros, Inc.'s upcoming investor event may reveal strategic insights and innovations, potentially impacting stock performance and investor sentiment in the water technology sector.
Source: MCAP MediaWire
Market Sentiment:
Neutral
Quick Summary
Nephros, Inc. (NEPH) held its Q1 2026 earnings call, discussing financial performance and business updates. Specific financial results and insights were shared during the call.
Why It Matters
Nephros, Inc.'s Q1 2026 earnings call provides insights into financial performance, guiding future expectations and investment strategies in the healthcare sector.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Nephros, Inc. (Nasdaq: NEPH) reported its financial results for Q1 2026, ending March 31. The company focuses on water filtration solutions for medical and commercial sectors.
Why It Matters
Nephros, Inc.'s Q1 financial results can indicate its growth trajectory and market performance, impacting stock valuation and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Nephros, Inc. announced news via PRISM MediaWire on April 30, 2026, from South Orange, NJ. Further details were not provided in the excerpt.
Why It Matters
Nephros, Inc.'s press release could signal new developments or partnerships, potentially impacting stock performance and market perception, affecting investment decisions.
Source: MCAP MediaWire
Market Sentiment:
Neutral
Frequently Asked Questions About NEPH Stock
What is Nephros Inc.'s (NEPH) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Nephros Inc. (NEPH) has a median price target of $7.00. The highest price target is $8.00 and the lowest is $6.00.
Is NEPH stock a good investment in 2027?
According to current analyst ratings, NEPH has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $3.78. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NEPH stock?
Wall Street analysts predict NEPH stock could reach $7.00 in the next 12 months. This represents a 85.2% increase from the current price of $3.78. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Nephros Inc.'s business model?
Nephros Inc. generates revenue through the development and sale of specialized filtration devices, including hemodiafilters and ultrafilters, primarily to medical institutions, commercial facilities, and the military sector. The company focuses on creating high-quality solutions that address the critical needs of clean water and effective dialysis treatments, thereby establishing a robust client base in various healthcare and industrial applications.
What is the highest forecasted price for NEPH Nephros Inc.?
The highest price target for NEPH is $8.00 from at , which represents a 111.6% increase from the current price of $3.78.
What is the lowest forecasted price for NEPH Nephros Inc.?
The lowest price target for NEPH is $6.00 from Anthony Vendetti at Maxim Group, which represents a 58.7% increase from the current price of $3.78.
What is the overall NEPH consensus from analysts for Nephros Inc.?
The overall analyst consensus for NEPH is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $7.00.
How accurate are NEPH stock price projections?
Stock price projections, including those for Nephros Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 2:44 AM UTC